Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard B S Roden

Showing results (1-10 of 140) with videos related to

Pageof 14
Sort By:
Vaccines|October 6, 2020
Progress in L2-Based Prophylactic Vaccine Development for Protection against Diverse Human Papillomavirus Genotypes and Associated DiseasesPola Olczak, Richard B S Roden
Virology|May 22, 2013
L2, the minor capsid protein of papillomavirusJoshua W Wang, Richard B S Roden
Nature Reviews. Cancer|March 3, 2018
Opportunities and challenges for human papillomavirus vaccination in cancerRichard B S Roden, Peter L Stern
Journal of Virology|November 13, 2009
Papillomavirus prophylactic vaccines: established successes, new approachesM Saveria Campo, Richard B S Roden
Expert Review of Vaccines|February 19, 2013
Virus-like particles for the prevention of human papillomavirus-associated malignanciesJoshua W Wang, Richard B S Roden
Gynecologic Oncology|June 14, 2008
The future of vaccines for cervical cancerWarner K Huh, Richard B S Roden
Virus Research|November 28, 2016
Developments in L2-based human papillomavirus (HPV) vaccinesChristina Schellenbacher, Richard B S Roden, Reinhard Kirnbauer
Current Opinion in Immunology|December 28, 2010
Prevention of cancer by prophylactic human papillomavirus vaccinesKihyuck Kwak, Anna Yemelyanova, Richard B S Roden
Scientific Reports|October 9, 2025
Nano-Luciferase complementation assay of human herpesvirus 8 chemo/cytokine-receptor interactionsVikrant Palande, Richard B S Roden, Young Bong Choi
European Journal of Immunology|January 30, 2008
Towards global prevention of human papillomavirus-induced cancerRichard B S Roden, Patti Gravitt, T-C Wu
Pageof 14

Showing results (1-10 of 140) with videos related to

Sort By:
Pageof 14
Vaccines|October 6, 2020
Progress in L2-Based Prophylactic Vaccine Development for Protection against Diverse Human Papillomavirus Genotypes and Associated DiseasesPola Olczak, Richard B S Roden
Virology|May 22, 2013
L2, the minor capsid protein of papillomavirusJoshua W Wang, Richard B S Roden
Nature Reviews. Cancer|March 3, 2018
Opportunities and challenges for human papillomavirus vaccination in cancerRichard B S Roden, Peter L Stern
Journal of Virology|November 13, 2009
Papillomavirus prophylactic vaccines: established successes, new approachesM Saveria Campo, Richard B S Roden
Expert Review of Vaccines|February 19, 2013
Virus-like particles for the prevention of human papillomavirus-associated malignanciesJoshua W Wang, Richard B S Roden
Gynecologic Oncology|June 14, 2008
The future of vaccines for cervical cancerWarner K Huh, Richard B S Roden
Virus Research|November 28, 2016
Developments in L2-based human papillomavirus (HPV) vaccinesChristina Schellenbacher, Richard B S Roden, Reinhard Kirnbauer
Current Opinion in Immunology|December 28, 2010
Prevention of cancer by prophylactic human papillomavirus vaccinesKihyuck Kwak, Anna Yemelyanova, Richard B S Roden
Scientific Reports|October 9, 2025
Nano-Luciferase complementation assay of human herpesvirus 8 chemo/cytokine-receptor interactionsVikrant Palande, Richard B S Roden, Young Bong Choi
European Journal of Immunology|January 30, 2008
Towards global prevention of human papillomavirus-induced cancerRichard B S Roden, Patti Gravitt, T-C Wu
Pageof 14